Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$405.9K
21.49K shares
What this filing means
BOBULSKY SUSAN plans to sell 21.49K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $405.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006690
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
21.49K
Shares to sell
$405.9K
Approx. market value
487.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/4/2022
487.00Total acquired487.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2022 | Restricted Stock Units N/A | 487.00 | — |
| Total | 487.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5K
Market value
$102.5K
6/25/2026
—Completed
Units to sell
5K
Market value
$95.0K
6/11/2026
—Completed
Units to sell
11K
Market value
$198.0K
6/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
487.00
Market value
$10.4K
7/1/2026
Total
Units
21.49K
Value
$405.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 5K | $102.5K | — | Completed |
6/11/2026 | 5K | $95.0K | — | Completed |
6/4/2026 | 11K | $198.0K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 487.00 | $10.4K | NASDAQ | Planned |
| Total | 21.49K | $405.9K | ||